Related Experiment Video
Updated: Jan 27, 2026

Author Spotlight: Advancing the Detection of Low-Frequency Mutations in Cancer Tissues
Published on: August 23, 2024
CD117 immunoexpression in oral and sinonasal mucosal melanoma does not correlate with somatic driver mutations in the
Jessica Maldonado-Mendoza1, Velia Ramírez-Amador2, Gabriela Anaya-Saavedra2
1Doctorate in Health and Biological Sciences Program, Universidad Autónoma Metropolitana-Xochimilco, Mexico City, Mexico.
Background:
Mutations on KIT and downstream genes of MAPK pathway that overstimulate cellular proliferation have been associated with primary oral and sinonasal melanomas (POSNM), but there is limited information that allows the use of personalized therapy. Thus, the aim of the present study was to determine a possible association between the C-KIT immunohistochemical expression with the presence of somatic driver mutations in NRAS, BRAF, KIT, MITF and PTEN on POSNM.
Methods:
A retrospective study included 62 tumour samples of an oncological reference centre in Mexico City (17-year period). Immunohistochemistry stain of C-KIT was carried out. Genomic DNA was obtained and used to assess hotspot mutations of KIT, NRAS, BRAF, MITF and PTEN through qPCR. Chi-square, Fisher's exact and the Mann-Whitney U tests were applied when necessary. The significance was set at P < 0.05.
Results:
Sixty-two cases were included, 74% were positive for C-KIT immunoexpression, all exhibited moderate/strong intensity. Ten (16.1%) samples harboured at least one mutation, 6.4% and 6.6% for NRASQ 61R and BRAFV 600E , respectively, followed by KITK624E (3.2%). No KITL 576P , MITF or PTEN mutations were identified. No significant correlation was observed between mutations and immunostaining (rs = -0.057, P = 0.765).
Conclusions:
Regardless of the high immunoexpression of C-KIT, there was no association with the MAPK mutations among POSNM samples. Thus, C-KIT immunohistochemistry is not a reliable tool to detect POSNM candidates for biological therapy.
Insights
C-KIT immunoexpression is common in primary oral and sinonasal melanomas (POSNM), but does not correlate with MAPK pathway mutations. C-KIT testing is unreliable for identifying POSNM patients eligible for targeted therapies.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Primary oral and sinonasal melanomas (POSNM) are linked to KIT and MAPK pathway mutations driving proliferation.
- Limited data exists for personalized therapy selection in POSNM.
- This study investigated the association between C-KIT expression and driver mutations in POSNM.
Purpose of the Study:
- To determine if C-KIT immunohistochemical expression correlates with somatic mutations in NRAS, BRAF, KIT, MITF, and PTEN in POSNM.
- To assess the utility of C-KIT as a biomarker for targeted therapy in POSNM.
Main Methods:
- Retrospective analysis of 62 POSNM tumor samples.
- C-KIT immunohistochemistry and qPCR for hotspot mutations (NRAS, BRAF, KIT, MITF, PTEN).
- Statistical analysis using Chi-square, Fisher's exact, and Mann-Whitney U tests (P < 0.05).
Main Results:
- 74% of POSNM samples showed C-KIT immunoexpression (moderate/strong intensity).
- Mutations were found in 16.1% of samples: NRAS (6.4%), BRAF (6.6%), and KIT (3.2%).
- No significant correlation was observed between C-KIT expression and MAPK pathway mutations (P = 0.765).
Conclusions:
- High C-KIT immunoexpression in POSNM does not associate with MAPK pathway mutations.
- C-KIT immunohistochemistry is not a reliable biomarker for predicting response to biological therapies in POSNM.
- Further research is needed to identify predictive biomarkers for personalized treatment in POSNM.
More Related Videos
08:54Imaging Spatial Reorganization of a MAPK Signaling Pathway Using the Tobacco Transient Expression System
Published on: March 20, 2016
10:41Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
Published on: March 29, 2017
Related Concept Videos
Overview of Somatic Sensory Pathways
The somatosensory system is divided into three main pathways: the dorsal (or posterior) column-medial lemniscus, spinothalamic (or anterolateral), and spinocerebellar pathways.
The dorsal...
Major Somatic Sensory Pathways
Cancers Originate from Somatic Mutations in a Single Cell
Mutations
MAPK Signaling Cascades
Correlations